[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100591564":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":25,"locations":29,"responsibleParty":45,"collaborators":47,"id":51,"slug":52,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":19,"eligibilityCriteria":57,"healthyVolunteers":53,"sex":58,"minAge":59,"maxAge":60,"enrollmentInfo":61,"targetDuration":19,"studyType":64,"phases":65,"briefSummary":67,"conditions":68,"keywords":71,"overallStatus":31,"whyStopped":19,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"Connecticut Children's Medical Center","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"ReSPECT","EXPERIMENTAL","Aims 2 and 3 involve a single-arm cohort study of the ReSPECT intervention using a pre-post design. Enrolled participants will complete a survey at baseline, immediately after intervention use, and at 2 months from study enrollment. All participants will also be invited to participate in a brief interview immediately after intervention use.",[13],"Behavioral: ReSPECT",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"BEHAVIORAL","ReSPECT is an interactive, web-based digital platform that integrates (1) an AYA-centered pre-visit questionnaire (PVQ) that will discretely alert clinicians to relevant SRH questions\u002Fconcerns, (2) targeted patient education on PVQ selections, and (3) clinician-centered guidance for addressing SRH issues. At enrollment, all participants will complete a baseline survey (T1). AYAs will have access to the ReSPECT digital platform and will receive the first prompt to complete the PVQ 3-5 days before their next clinic appointment. Once completed, AYAs will receive an email\u002Ftext with a link to tailored information based on their PVQ selections for review. Clinicians will receive an email with a link to the patient's PVQ results on the ReSPECT platform along with clinical management recommendations. All participants will complete a brief virtual survey (T2) and interview within 48 hours of the first postintervention clinic visit and a follow-up survey 2 months after study enrollment (T3).",[9],null,[21],{"name":22,"affiliation":23,"role":24},"Natasha Frederick, MD, MPH","nfrederick@connecticutchildrens.org","PRINCIPAL_INVESTIGATOR",[26],{"name":22,"role":27,"phone":28,"phoneExt":19,"email":23},"CONTACT","860-545-9618",[30],{"facility":5,"status":31,"city":32,"state":33,"zip":34,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"RECRUITING","Hartford","Connecticut","06106","United States","US",{"type":38,"coordinates":39},"Point",[40,41],-72.68509,41.76371,{"lat":41,"lon":40},[44],{"name":22,"role":27,"phone":28,"phoneExt":19,"email":23},{"type":46,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR",[48],{"name":49,"class":50},"National Cancer Institute (NCI)","NIH","100591564","improving-communication-between-aya-oncology-patients-and-clinicians-a-patient-centered-intervention-100591564",false,"NCT06982066","Improving Communication Between AYA Oncology Patients and Clinicians: A Patient-Centered Intervention","Improving Health-Related Quality of Life Communication Between AYA Oncology Patients and Clinicians: A Patient-Centered Intervention","Inclusion Criteria\n\nAdolescent and Young Adult Oncology Patients\n\nIn order to be eligible to participate in this study, an individual must meet all of the following criteria:\n\n1. Be aged 15-25 years old at time of enrollment.\n2. Have a cancer diagnosis and currently be on cancer-directed therapy with at least one of the following:\n\n   1. Chemotherapy: any anticancer drug to treat the cancer diagnosis, including immunotherapy.\n   2. Radiotherapy: any radiotherapy to treat the cancer diagnosis.\n   3. Surgery: any surgery to remove cancer including partial of total resections. Biopsies are not considered surgery.\n3. Be greater than or equal to 2 months from diagnosis\u002Finitiation of therapy, whichever occurred later.\n4. Be able to speak and read English\n5. Have permission to participate from a member of the patient's primary oncology team.\n6. Provision to sign and date the consent\u002Fassent form.\n7. Active study participation of primary oncology clinician\n8. Patient must have primary oncology care at Connecticut Children's Center for Cancer \\& Blood Disorders of Children's Hospital Los Angeles Cancer \\& Blood Disease Institute\n\nExclusion Criteria\n\nAn individual who meets and of the following criteria will be excluded from participation in this study:\n\n1. Not currently on cancer-directed therapy.\n2. Unable to speak and read English.\n3. Insufficient cognitive functioning to complete study measures (as determined by a member of the patient's primary oncology team)\n\nPediatric Oncology Clinicians\n\n1\\. Be a pediatric oncology physician, clinical fellow, or advanced practice provider (including nurse practitioners and physician assistants) that provides clinical care for AYA patients with cancer","ALL","15 Years","25 Years",{"count":62,"type":63},60,"ESTIMATED","INTERVENTIONAL",[66],"NA","The overarching goal is to develop and demonstrate proof-of-concept of ReSPECT (Reproductive and Sexual Health Patient Education and Communication Tool), a multi-modal communication intervention to improve adolescent and young adult (AYA)- clinician sexual and reproductive health (SRH) communication in the outpatient oncology clinic setting.",[69,70],"Pediatric Cancer","Adolescent and Young Adult Cancer",[72,73,74,75,76],"adolescent young adult","sexual health communication","cancer","patient provider communication","sexual and reproductive health","2025-08-11",{"date":79,"type":80},"2025-08-14","ACTUAL",{"date":82,"type":80},"2025-02-10",{"date":84,"type":63},"2029-06-29",{"name":5,"class":6},1]